Eun Yang analyst JEFFERIES

Currently out of the existing stock ratings of Eun Yang, 94 are a BUY (72.31%), 31 are a HOLD (23.85%), 5 are a SELL (3.85%).

Eun Yang

Work Performance Price Targets & Ratings Chart

Analyst Eun Yang works at JEFFERIES with a stock forecast success ratio of 55.82% fulfilled within 239.21 days on average.

Eun Yang’s has documented 252 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TSHA, Taysha Gene Therapies  at 14-May-2024.

Wall Street Analyst Eun Yang

Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 6/8/2022. The price target of $1 was fulfilled within 9 days with a profit of $0.3 (42.86%) receiving and performance score of 47.62.

Average potential price target upside

ALBO Albireo Pharma ALXN Alexion Pharmaceuticals AMAG AMAG Pharmaceuticals AMGN Amgen BBIO BridgeBio Pharma BPMC Blueprint Medicines Corp CNTA Centessa Pharmaceuticals PLC ADR FPRX Five Prime Therapeutics LJPC La Jolla Pharmaceutical Co RDUS Schnitzer Steel Industries RIGL Rigel Pharmaceuticals TBIO Telesis Bio . UTHR United Therapeutics BMRN Biomarin Pharmaceutical HALO Halozyme Therapeutics ARWR Arrowhead Pharmaceuticals NCNA NuCana PLC LUMO Lumos Pharma ATXS Astria Therapeutics CVAC CureVac NV GBIO Generation Bio Co OPK Opko Health PYXS Pyxis Oncology WVE Wave Life Sciences Ltd TSHA Taysha Gene Therapies  BMEA Biomea Fusion RPHM Reneo Pharmaceuticals AVTE Aerovate Therapeutics RLYB Rallybio Corp

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$-2.15 (-4.87%)


1 years 3 months 3 days ago

0/15 (0%)

$-2.18 (-4.93%)



$-2.15 (-4.87%)


1 years 4 months 7 days ago

0/4 (0%)

$-2.1 (-4.76%)



$-2.15 (-4.87%)


1 years 4 months 7 days ago

0/3 (0%)

$-2.1 (-4.76%)



1 years 4 months 7 days ago

0/1 (0%)

$36.77 (201.70%)



$-2.15 (-4.87%)


1 years 4 months 9 days ago

0/2 (0%)

$-1.85 (-4.22%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Eun Yang is most bullish on?

Potential upside of $44.43 has been obtained for AVTE (AEROVATE THERAPEUTICS)

Which stock is Eun Yang is most reserved on?

Potential downside of -$0.27 has been obtained for RLYB (RALLYBIO CORP)

What Year was the first public recommendation made by Eun Yang?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?